Research Radboud technology centers Radboud Biobank News Sub-biobank Rare Geneitic Diseases
23 April 2019

Because there are so many different rare genetic diseases, and often only a few patients with the same genetic disease visit the Radboudumc, frequently these patients cannot be accommodated in a "disease-specific biobank".

The aim of the Biobank Genetics and Rare Disease (GRD) is to offer these patients the opportunity to participate in future research aimed at improving care for people with a rare genetic disease in the fields of recognition, diagnosis, and treatment. Collecting biomaterial plus the associated clinical data of these patients will contribute to this. The DNA of the parents of some of the participants will also be stored for the interpretation of a genetic variant.
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


Sub-biobank MEMORY

15 September 2020

The MEMORY biobank focuses on research into biomarkers for memory impairment and dementia and their validation in clinical cohorts.

read more

RYR1 sub-biobank

15 September 2020

The RYR1 biobank is part of a study of the neuromuscular and multisystem features of patients with malignant hyperthermia or rhabdomyolysis related to RYR1 (ryanodine receptor type 1) variants.

read more

New colleague

15 September 2020

My name is Robbert Croes and I started mid 2020 as a data-scientist at the Radboud Biobank.

read more

ProBCI sub-biobank

15 September 2020

There is a pressing need for predictive biomarkers to personalize bladder cancer treatment.

read more

Financial regulation for sub-biobanks

15 September 2020

Sub-biobanks are not required to pay up-front for the processing and storage of biomaterials. The effectiveness of this pre-financing agreement however is dependent on adherence to the demands regarding delivery and processing according to the Radboud Biobank standard operating procedures.

read more